8 Magnificent Dividend Growth Stocks to Buy Now
This year, dividend stocks have underperformed compared to the broader market, largely because tech stocks have captured most of the attention.
Abbott Laboratories (ABT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 11,102,204 | $1,265,762,424 | +6% | 0.51% |
| 2. | Diamond Hill Capital Ric Dillon | 6,683,586 | $761,995,640 | +9% | 3.08% |
| 3. | Two Sigma Advisors John Overdeck And David Siegel | 3,908,200 | $445,573,882 | -17% | 1.04% |
| 4. | Sessa Capital John Petry | 3,749,502 | $427,480,723 | +48% | 15.75% |
| 5. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 2,530,201 | $288,468,216 | +10% | 0.24% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $122.50 | 2,040 | 7,296 | 2021-02-23 | Filing | ||
| $73.40 | 2,000 | Officer | 52,562 | 2019-04-22 | Filing | |
| $72.32 | 100 | Director | 6,400 | 2019-01-31 | Filing | |
| $72.31 | 100 | Director | 6,300 | 2019-01-31 | Filing | |
| $72.33 | 1,800 | Director | 6,200 | 2019-01-31 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $116.98 | 150,271 | 184,806 | 2024-10-21 | Filing | ||
| $118.15 | 5,901 | 335,077 | 2024-10-21 | Filing | ||
| $118.81 | 1,249 | 340,978 | 2024-10-21 | Filing | ||
| $116.90 | 61,380 | 220,059 | 2024-09-12 | Filing | ||
| $116.04 | 80,299 | 281,439 | 2024-09-12 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 156,444,700 | $17,219,868,129 | 0.37% | |
| 2. | 134,064,516 | $14,756,481,316 | 0.37% | |
| 3. | 86,588,614 | $9,530,825,115 | 2.34% | |
| 4. | 74,687,176 | $8,220,817,462 | 0.39% | |
| 5. | 64,294,784 | $7,077,147,935 | 1.58% |
News See All
UBS' Best Stocks In The AI, Growth & Low Rates Era: Top 29 US Stocks
The stock market at the tail end of 2024 is an evolution of the patterns we've observed since the start of the coronavirus pandemic.
10 Best Pharma Stocks To Buy Right Now
Healthcare takes the concept of 'defensive' further than almost any industry, encompassing many companies that provide patient care, engage in the research and development of new treatments, and design...
Organic Growth and Margin Expansion Make Abbott Laboratories (ABT) A Solid Investment
Abbott Laboratories (ABT) stock has had negative returns for the last 3 years. But don't get fooled by that when analyzing the stock's performance.
Abbott Laboratories (NYSE:ABT) Q3 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to Abbott's Third Quarter 2024 Earnings Conference Call.
10 Best Medical Stocks to Buy Now
The medical and healthcare industry is one of the largest globally, with a steady demand for products and services due to the biological nature of humans. Stocks like Pfizer Inc.
Jim Cramer is Talking About These 14 Stocks Before Earnings
As earnings season kicks off, Jim Cramer of Mad Money offered insights on what investors should watch in the coming week on Wall Street.
10 Buzzing AI Health Stocks
The economic impact of AI is projected to be substantial, particularly in regions like China and North America, which are expected to see GDP boosts of 26% and 14.5%, respectively, by 2030, amounting ...
7 Best Dialysis and Kidney Disease Stocks to Buy
The global kidney treatment and dialysis market is experiencing typical growth levels.
10 Best Healthcare Stocks To Buy According to Hedge Funds
Investing in healthcare equities is typically seen as protective during difficult economic times.